-
Company Insights
Innovation and Patenting activity of Ventia Services Group Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Ventia Services Group Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Company Profile
CIMIC Group Ltd – Company Profile
CIMIC Group Ltd (CIMIC), a subsidiary of HOCHTIEF Australia Holdings Limited, is a provider of infrastructure construction and contracting services. It offers project development, construction, contract mining, property and infrastructure development, and operation and maintenance services. The company serves public and private sector clients across a variety of end markets including construction, health care, oil and gas, educational, transportation, and others. It offers services under various brand names Broad, CPB Contractors, EIC Activities, Leighton Asia, Pacific Partnerships, Sedgman, Ventia and...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – alpha-1 proteinase inhibitor (human)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry alpha-1 proteinase inhibitor (human) Drug Details Alpha1-proteinase inhibitor, human (Glassia/ Ventia/ Respikam) also known...